No brainer for BrainZ
Wednesday, 08 October, 2008
BrainZ Instruments [ASX: BZI] is to be acquired by the US-based Natus Medical for NZ$1.3 million [AUD$1.13 million].
Pending shareholder approval, Natus will acquire essentially every trading asset of BrainZ - including products, IP and brand – except the company's cash reserves.
If the arrangement goes ahead, Natus will assume a number of the company’s distribution and customer support obligations.
BrainZ has developed a bedside brain monitoring technology that assists in the detection of brain injury and seizure activity in neonates.
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
5-in-1 meningococcal vaccine proves effective
A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...
Diabetes drug reduces knee arthritis pain in overweight patients
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or...
